Neutrophil functions are initiated within seconds after stimulus addition in response to N-formyl chemotactic peptides and precede ligand-receptor internalization [ 1-51. We have biochemical evidence from subcellular fractionation studies [3, 61 and covalently labelling the receptor by means of a radioiodinated photoactivatable arylazido derivative of the hexapeptide CHO-Nle-Leu-Phe-Nle-Tyr-Lys [ 71 which suggests that internalization of N-formyl peptides proceeds by passage of an occupied receptor in a high-affinity complex from the cell surface to organelles co-sedimenting with the light density Golgi complex. Subsequently, receptors translocate into a granule-rich fraction and N-formyl peptides accumulate in the cytosol.
Neutrophil functions are initiated within seconds after stimulus addition in response to N-formyl chemotactic peptides and precede ligand-receptor internalization [ 1-51. We have biochemical evidence from subcellular fractionation studies [3, 61 and covalently labelling the receptor by means of a radioiodinated photoactivatable arylazido derivative of the hexapeptide CHO-Nle-Leu-Phe-Nle-Tyr-Lys [ 71 which suggests that internalization of N-formyl peptides proceeds by passage of an occupied receptor in a high-affinity complex from the cell surface to organelles co-sedimenting with the light density Golgi complex. Subsequently, receptors translocate into a granule-rich fraction and N-formyl peptides accumulate in the cytosol.
We are now able to visualize continuously, in real-time, the interaction of the fluorescent tetramethylrhodamine (TMR)-conjugated derivative of the same N-formyl peptide, TMRpeptide 141, with single human neutrophils by fluorescence microscopy in the presence of excess free peptide, and correlate fluorescence distribution and cell shape.
Methodology
The association of fluorescent TMR-peptide with neutrophils was recorded at 23°C in the presence or absence of a 20-fold molar excess of unlabelled parent hexapeptide. Light transmission and fluorescence images were stored on video tape and photographs were taken from the monitor screen.
The essential features of the test system are:
(1) Binding of fluorescent TMR-peptide could be visualized by laser scan or video intensification microscopy at 0.5 nM, a concentration which yields about half-maximal saturation of the available surface receptors [8] and found to be optimal for the polarization of neutrophils.
(2) Washing of the cells after association with TMRpeptide was not required which allowed the visual observation of single cell fluorescence in real-time [9] . At the excitation/emission wavelengths required for TMR-peptide detection, autofluorescence of neutrophils was very low.
(3) TMR-peptide fluorescence intensity was not changed by acidification or mild oxidation, which favours the use of TMR-peptide over fluorescein isothiocyanate (FITC)-peptide to investigate the fate of N-formylated peptides in living human neutrophils.
(4) Ligands which were bound to the outside of neutrophils were rapidly dissociated by acidification of the incubation medium, resulting in a decrease of fluorescence which allowed us to distinguish visually between fluorescent ligands bound to the cell surface and those which were internalized.
For video intensification microscopy, 200 000 initially spherical neutrophils in 1 ml of Dulbecco's phosphatebuffered saline supplemented with 0.5 mM-MgC1,/1 mMCaClz/glucose (1 g/l) (DPBS) and 0.04% (w/v) fibrinogen (Kabi, Stockholm, Sweden) were placed in a Sykes-Moore chamber at 23°C. Under these conditions neutrophils do not adhere to the glass substratum 191. After the addition of 0.5 nM-TMR-peptide, however, neutrophils polarize and adhere Abbreviations used: CHO-, forrnyl; Nle, norleucine; TMR, tetramethylrhodamine; FITC, fluorescein isothiocyanate; DPBS, Dulbecco's phosphate-buffered saline supplemented with 0.5 MMgCIJ1 rnM-CaClJglucose ( I g/l).
to the glass substratum. Cell morphology and fluorescence were recorded continuously.
For lascr scan microscopy [ 10, 1 11 200000 initially spherical neutrophils in 1 ml of DPBS-0.04% (w/v) fibrinogen were incubated with 0.5 nM-TMR-peptide at 23°C for 10 min and then placed on a microscope slide, covered with a cover slip, and immediately assessed for cellassociated fluorescence. Light transmission and fluorescence images were recorded (2 s/image).
Binding and processing of TMR-peptide by suspended humun neiitrophils
When suspended human neutrophils were incubated with 0.5 nM-TMR-peptide at 23"C, the following sequence of ligand binding and internalization was observed by video intensification and laser scan microscopy ( Fig. 1 ) .
(1) Rapid homogeneous diffuse binding of TMR-peptide (0-90 s) to neutrophils, but not to eosinophils. Cells are still spherical and without ruffles. Ruffles appear within 3 rnin after stimulus addition.
(2) Clearance of fluorescence from the surface and accumulation of fluorescent ligands into a cap (3-6 min). No front-tail polarity. Adherence.
( 3 ) Approx. 6 min after TMR-peptide addition, neutrophils start to polarize. The fluorescent cap region is localized to the uropod (tail) of the polarized neutrophil. Neutrophils are motile.
(4) Fluorescent vesicular structures are gradually translocated from the uropod to the perinuclear region of the neutrophil (6-22 min). Little binding, only, of TMR-peptide to the front ruffled region is detected.
(5) By approx. 30 min, generation of several randomly distributed small-and medium-sized fluorescent spots is observed within the polarized neutrophil, exhibiting the typical saltatory movements of internal vesicular structures. Some fluorescence is still seen at the uropod.
Binding and processing of TMR-peptide by colchicinepretreated suspended human neiitrophils
Treatment of neutrophils with lo-' M-colchicine (Sigma, Munchen, F.R.G.) destroys the microtubular network of cells [ 121, but has no apparent effect on neutrophil polarization by N-formyl peptides [ 131. We observed that colchicine pretreatment of neutrophils affected TMR-peptide processing and cell shape (Fig. 2) . After the addition of 0.5 nM-TMRpeptide to colchicine-pretreated neutrophils, the polarized cells assumed a spherical non-polarized shape with surface ruffles within 7 0 s. Within this time binding of TMR-peptide to the cells was diffuse and homogeneous. After the initial step of ligand binding cells polarized and formed a fluorescent cap at the uropod of the cell (within 3-8 min after addition of TMR-peptide).
We observed a major difference in ligand processing by colchicine-treated neutrophils compared with controls which received no colchicine pretreatment: translocation of fluorescent ligands from the uropod to the perinuclear region of the cells was abolished in colchicine-treated neutrophils. Fluorescent ligands sequestered directly into motile vesicular structures without taking the route through the perinuclear region of the cell. Substituting colchicine by the lightinactivated colchicine-derivative lumicolchicine (Sigma, Munchen, F.R.G.) did not result in an inhibition of the ligand traffic from the tail to the perinuclear region. 
Binding and processing of TMR-peptide by cytochalusin-Bpretreated siispended human neutrophils
In order to investigate whether cap formation and translocation of fluorescent TMR-peptide into the mid-section of the neutrophil might be associated with the polarized morphology of the cells, neutrophils were treated with cytochalasin B (Sigma, Miinchen, F.R.G.). Cytochalasin B is known to inhibit the polarization response to N-formyl chernotactic peptides [ 9 ] .
Cytochalasin-B-pretreated neutrophils do not polarize in response to TMR-peptide (Fig. 3) . N o asymmetrical redistribution of ligand-receptor complexes was observed. The initial homogeneous distribution of TMR-peptide on the neutrophil surface disappeared within 20 min after TMRpeptide addition and accumulated in several small-and medium-sized spots. These fluorescent spots most probably represent intracellular vesicular structures.
Assessment of binding of TMR-peptide to sitspended hitman tieittrophils by cytofliiorimetty
It was also possible to follow binding and internalization of TMR-peptide by cytofluorimetry (FACS IV; BectonDickinson, Heidelberg, F.R.G.). This approach allowed quantification of the uptake of fluorescent chemotactic peptide by the neutrophil at different time points within a few seconds. As antibodies to TMR quench free TMRpeptide, but not the fluorescence of receptor-bound or internalized TMR-peptide, it was possible to exactly quantify the numbers of TMR-peptide per cell.
Cell-surface-receptor-bound TMR-peptide is dissociated by acidic pH (approx. pH 3). Thus by lowering the pH it is possible to discriminate between cell-surface-bound and internalized TMR-peptide. The same approach can be used with FITC-peptide 15, 81. Lowering the pH below 5 . however, results in an almost complete quenching of fluorescence. By this criterion it is also possible to discriminate between internal and cell-surface-associated fluorescence [3, 4, 6, 7, 9 , 101, clustering of receptor-ligand complexes [3, 4, 6, 7, 9 , 101, and the passage of an occupied receptor in the form of receptosomes [3, 6, 91 to the perinuclear Golgi region of the cell [3, 4, 7, 9 , 101 from where the fluorescent ligand is translocated into intracellular motile vesicular structures [3, 4, 6, 9, 10, 171 . The microscopic observations on binding of TMRpeptide to neutrophils, which were treated with the cytoskeleton-destroying drugs, cytochalasin B or colchicine, give rise to the following conclusions:
(1) Neutrophils treated with cytochalasin B before TMRpeptide binding do not polarize and do not show any asymmetrical distribution of ligand-receptor complexes, suggesting that N-formyl-peptide-induced front-tail polarity of neutrophils is associated with asymmetric redistribution of ligand-receptor complexes.
(2) Colchicine pretreatment of neutrophils exerts no apparent inhibitory effect on TMR-peptide internalization, suggesting that intact microtubules are not necessary for the removal of receptor-ligand complexes from the cell surface. After the initial step of ligand binding to the cell surface at elevated temperatures, fluorescent TMR-peptides aggregate and accumulate into a cap at the rear end of the neutrophil even in colchicine-pretreated cells. Evidently, aggregation and cap formation of TMR-peptide may proceed independently of an intact microtubular network.
(3) The passage of clustered TMR-peptides from the rear end of a polarized neutrophil to the perinuclear region of the neutrophil is blocked by colchicine pretreatment. Tentatively, we conclude from these observations that the passage of TMR-peptide from the rear end to the perinuclear region of the neutrophil depends on an intact microfilament network.
Sullivan et al.
[ 141 used scanning electron microscopy to investigate the binding of a haemocyanin-linked N-formyl peptide to surface receptors on polarized but glutaraldehyde-fixed rabbit peritoneal neutrophils. These authors demonstrated surface binding of this ligand to the front and the mid-section of the cell. In contrast to Sullivan et al. [ 141, we described the fate of the fluorescent N-formyl peptide TMR-peptide in living polarized human neutrophils in realtime in the presence of excess free ligand. Thereby novel BIOCHEMICAL SOCIETY TRANSACTIONS features of the processing of N-formyl peptides by neutrophils were uncovered that may be significant for ligandreceptor processing and cell activation. These findings correlate well with our results obtained biochemically by tracing the receptor in stimulated neutrophils by means of photoaffinity labelling and subcellular fractionation techniques [ 1, 3, 7] .
Introduction
Interferon (1FN)-yis a member of a group of IFN proteins which display an array of biological effects on almost all cells of the immune system. The effects of IFN-y on monocytes/ macrophages can influence cell differentiation, inflammation, host defence and tissue repair [ 1, 21. Some of the more specific effects of IFN-y on these cells include enhancement of Abbreviations used: IFN, interferon; rlFN-y, recombinant interferon-y; PMN, polymorphonuclear leucocytes.
Fc receptors 131, increased expression o f class II histocompatibility antigens [4] , and tumoricidal [S] and microbicidal [6] activity; these effects may occur at very low concentrations of IFN-y (1-3 PM). In order t o develop responsiveness at such low concentrations of ligand, a highly specific receptor system has evolved on macrophages and other cells of the immune system. However, since most of the effector functions of macrophages required 24-72 h for expression, there is only incomplete information on the mechanisms underlying the ability o f IFN-y to induce such effects. Our laboratory has approached the question of signal transduction b y initially defining the characteristics of the receptor-ligand interaction and the immediate post-binding effects of this interaction in human monocytes, neutrophils and monocyte-like cell lines.
